UBS Group’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,740
| Closed | -$197K | – | 10261 |
|
|
2023
Q2 | $197K | Sell |
4,740
-224,758
| -98% | -$9.23M | ﹤0.01% | 5487 |
|
|
2023
Q1 | $9.48M | Sell |
229,498
-230,753
| -50% | -$9.87M | ﹤0.01% | 1931 |
|
|
2022
Q4 | $19M | Buy |
460,251
+238,433
| +107% | +$9.65M | 0.01% | 1458 |
|
|
2022
Q3 | $9.72M | Sell |
221,818
-532,828
| -71% | -$25.8M | ﹤0.01% | 1812 |
|
|
2022
Q2 | $37.1M | Sell |
754,646
-320,456
| -30% | -$17.2M | 0.02% | 915 |
|
|
2022
Q1 | $61M | Buy |
1,075,102
+449,937
| +72% | +$23.9M | 0.02% | 748 |
|
|
2021
Q4 | $32.8M | Buy |
625,165
+169,828
| +37% | +$9.23M | 0.01% | 1230 |
|
|
2021
Q3 | $27.3M | Buy |
455,337
+439,043
| +2,695% | +$27.1M | 0.01% | 1260 |
|
|
2021
Q2 | $1.1M | Sell |
16,294
-1,886
| -10% | -$129K | ﹤0.01% | 4097 |
|
|
2021
Q1 | $1.19M | Sell |
18,180
-33,315
| -65% | -$2M | ﹤0.01% | 4084 |
|
|
2020
Q4 | $2.9M | Buy |
51,495
+15,524
| +43% | +$764K | ﹤0.01% | 3017 |
|
|
2020
Q3 | $1.75M | Buy |
35,971
+15,456
| +75% | +$833K | ﹤0.01% | 3172 |
|
|
2020
Q2 | $1.14M | Sell |
20,515
-17,494
| -46% | -$1.01M | ﹤0.01% | 3398 |
|
|
2020
Q1 | $1.93M | Sell |
38,009
-79,901
| -68% | -$5.36M | ﹤0.01% | 2801 |
|
|
2019
Q4 | $9.12M | Buy |
117,910
+47,024
| +66% | +$3.32M | ﹤0.01% | 2036 |
|
|
2019
Q3 | $4.49M | Buy |
70,886
+34,207
| +93% | +$2.14M | ﹤0.01% | 2484 |
|
|
2019
Q2 | $2.15M | Buy |
36,679
+20,276
| +124% | +$1.2M | ﹤0.01% | 3080 |
|
|
2019
Q1 | $931K | Sell |
16,403
-27,681
| -63% | -$1.47M | ﹤0.01% | 3638 |
|
|
2018
Q4 | $2.19M | Buy |
44,084
+4,370
| +11% | +$263K | ﹤0.01% | 2949 |
|
|
2018
Q3 | $2.82M | Sell |
39,714
-20,068
| -34% | -$1.28M | ﹤0.01% | 2885 |
|
|
2018
Q2 | $3.12M | Sell |
59,782
-20,912
| -26% | -$1.1M | ﹤0.01% | 2762 |
|
|
2018
Q1 | $4.21M | Sell |
80,694
-5,806
| -7% | -$294K | ﹤0.01% | 2465 |
|
|
2017
Q4 | $5.06M | Sell |
86,500
-338
| -0.4% | -$19.2K | ﹤0.01% | 2347 |
|
|
2017
Q3 | $4.82M | Buy |
86,838
+13,517
| +18% | +$894K | ﹤0.01% | 2246 |
|
|
2017
Q2 | $5.64M | Sell |
73,321
-24,258
| -25% | -$1.81M | ﹤0.01% | 2043 |
|
|
2017
Q1 | $7.29M | Sell |
97,579
-67,968
| -41% | -$4.93M | ﹤0.01% | 1753 |
|
|
2016
Q4 | $11.2M | Sell |
165,547
-115,674
| -41% | -$7.46M | 0.01% | 1415 |
|
|
2016
Q3 | $18.7M | Buy |
281,221
+18,865
| +7% | +$1.2M | 0.01% | 1024 |
|
|
2016
Q2 | $15.7M | Buy |
262,356
+242,646
| +1,231% | +$13.1M | 0.01% | 1088 |
|
|
2016
Q1 | $959K | Sell |
19,710
-1,050
| -5% | -$47.6K | ﹤0.01% | 3295 |
|
|
2015
Q4 | $1.12M | Buy |
20,760
+46
| +0.2% | +$2.35K | ﹤0.01% | 3315 |
|
|
2015
Q3 | $998K | Sell |
20,714
-428
| -2% | -$22.1K | ﹤0.01% | 3359 |
|
|
2015
Q2 | $1M | Sell |
21,142
-512
| -2% | -$23.9K | ﹤0.01% | 3569 |
|
|
2015
Q1 | $995K | Buy |
21,654
+1,625
| +8% | +$75.5K | ﹤0.01% | 3586 |
|
|
2014
Q4 | $944K | Buy |
+20,029
| New | +$835K | ﹤0.01% | 3617 |
|
Other funds holding NUVA
UBS Group's NUVA Position: Q3 2023 in Review
UBS Group sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 4,740 shares — an estimated $197K sold.
UBS Group first reported a position in NUVA in Q4 2014 and held it in 35 quarters. The position peaked at $61M in Q1 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- UBS Group reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- UBS Group sold 4,740 NuVasive, Inc. shares in Q3 2023, an estimated $197K.
- UBS Group first reported a position in NuVasive, Inc. in Q4 2014 and held it in 35 quarters.
- UBS Group's NuVasive, Inc. position peaked at $61M in Q1 2022.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.